Lataa...

Galectin-9 modulates immunity by promoting Th2/M2 differentiation and impacts survival in patients with metastatic melanoma

PURPOSE: Galectin-9, a β-galactoside binding protein, is defined as a negative regulator of T helper 1 (Th1) immune responses, favoring Th2 bias. Systemic immunity in patients with metastatic melanoma is predominately Th2 biased. We hypothesized galectin-9 could modulate systemic immunity toward Th2...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Melanoma Res
Päätekijät: Enninga, Elizabeth Ann L., Nevala, Wendy K., Holtan, Shernan G., Leontovich, Alexey A., Markovic, Svetomir N.
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: 2016
Aiheet:
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC5929986/
https://ncbi.nlm.nih.gov/pubmed/27455380
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/CMR.0000000000000281
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!